Jane Armer, PhD, RN, FAAN

 

Professor Emerita

Director, Nursing Research, Ellis Fischel Cancer Center 
Director, American Lymphedema Framework Project

E-mail: armer@missouri.edu
Phone: 573.882.0287
Fax: 573.884.4544

S312 Sinclair School of Nursing
University of Missouri
Columbia, MO 65211

DC 116.05 Suite 408
Ellis Fischel Cancer Center
115 Business Loop 70 W.
Columbia, MO 65203

 

Graduate Faculty Status – Yes
DNP Doctoral Faculty Status – Yes
PhD Doctoral Faculty Status – Yes

 

Program of Research

Jane Armer is a professor at the MU Sinclair School of Nursing and Director of Nursing Research at Ellis Fischel Cancer Center. In 2000 she was appointed to the Medical Advisory Committee of the National Lymphedema Network (NLN). In 2008, she became the founding director of the American Lymphedema Framework Project. She serves on the Board of Directors of the Lymphedema Association of North America (LANA). She is a nurse scientist member of the Alliance, the national medical oncology clinical trials research group, where she is a member of the oncology nursing group and the symptom intervention subcommittee.

 

Selected Grants, Honors and Awards
  • Honorary Alumni Awardee, MU Nursing Alumni Association, 2021
  • Interdisciplinary Research Training in Health Behavior Science (T32) — National Institutes of Health, 2016-2021
  • The Lymphedema and Gynecologic Cancer (LEG) Study: Incidence, Risk Factors and Impact — Sloan-Kettering Institute for Cancer Research Subcontract (Prime: National Institute of Health), 2011-2016
  • Genetic Predisposition to Post-Breast Cancer Lymphedema – Mizzou Advantage –  2012-2013
    Cyber Informatics Tools for Lymphedema Stakeholders – National Library of Medicine G08 Co-PI (PI Shyu).  2010-2013
  • Cyber Informatics Tools for Lymphedema Stakeholders – National Library of Medicine G08 Co-PI (PI Shyu). 2010-2013
  • Early identification and treatment of lymphedema in women with breast cancer: Evaluation of early use of compression to prevent progression and its impact on quality of life and arm function. National Institutes of Health; Massachusetts General Hospital. R01. Consultant (PI Taghian). 2009-2013
  • Aqua Lymphatic Therapy The Tidhar Method ® – Risk Reduction and Overall Well-being for Breast Cancer Survivors — Susan G. Komen for the Cure. 2012-2013
  • Mid-Missouri Affiliate of Susan G. Komen for the Cure and MU Sinclair School of Nursing Partnership for Breast Cancer Awareness and Survivorship Education – Susan G. Komen for the Cure. 2011-2012 
  • Research Dissemination Award for American Lymphedema Framework Project, Sigma Theta Tau International, 2017
  • Inductee, Nurse Researcher Hall of Fame, Sigma Theta Tau International, 2017
  • Connie H. Yarbro Oncology Mentoring Award, Oncology Nursing Society, 2009
  • Outstanding Contribution to Research, Internaionational Lymphoedema Framework, 2009
  • Fellow, American Academy of Nursing, 2008
        •  

 

Selected Publications
  • Paskett, E. D., Le‐Rademacher, J., Oliveri, J. M., Liu, H., Seisler, D. K., Sloan, J. A., Armer, J. M.… & Loprinzi, C. (2021). A randomized study to prevent lymphedema in women treated for breast cancer: CALGB 70305 (Alliance). Cancer127(2), 291-299.
  • Russo, S., Walker, J. L., Carlson, J. W., Carter, J., Ward, L. C., Covens, A., Tanner, E.J., Armer, J. M. … & McCaskill-Stevens, W. (2021). Standardization of lower extremity quantitative lymphedema measurements and associated patient-reported outcomes in gynecologic cancers. Gynecologic Oncology160(2), 625-632.
  • Naughton, M. J., Liu, H., Seisler, D. K., Le‐Rademacher, J., Armer, J. M., Oliveri, J. M., … & Paskett, E. D. (2021). Health‐related quality of life outcomes for the LEAP study—CALGB 70305 (Alliance): A lymphedema prevention intervention trial for newly diagnosed breast cancer patients. Cancer127(2), 300-309.
  • Anbari, A. B., Wanchai, A., & Armer, J. M.(2021). Breast cancer-related lymphedema and quality of life: A qualitative analysis over years of survivorship. Chronic illness17(3), 257-268.
  • Hulett, J. M., Johnstone, B., Armer, J. M.,Deroche, C., Millspaugh, R., & Millspaugh, J. (2021). Associations between religious and spiritual variables and neuroimmune activity in survivors of breast cancer: a feasibility study. Supportive Care in Cancer, 1-9.
  • Hulett, J. M., Abshire, D. A., Armer, J. M.,Millspaugh, R., & Millspaugh, J. (2021). Rural-Urban Differences in Neuroimmune Biomarkers and Health Status Among Women Living With Breast Cancer. Cancer nursing44(4), 323-332.
  • Anbari, A. B., Sun, Y., McCaffrey, S., Morton, J., & Armer, J. M. (2021). The impact of breast cancer-related lymphedema on rural and small-town Survivors’ return-to-work and quality of life: A multiple-case study. Cancer Treatment and Research Communications29, 100459.
  • Armer, J.M., Ostby, P.L., Ginex, P.K., Beck, M., Deng, J., Fu, M., … Morgan, R.L. (2020). ONS Guidelines™ for Cancer Treatment–Related Lymphedema. Oncology Nursing Forum, 47(5), 518-538 DOI: 10.1188/20.ONF.518-538.
  • Carter, J., Huang, H. Q., Armer, J., Carlson, J. W., Lockwood, S., Nolte, S., Kauderer, J., Hutson, A., Walker, J. L., Fleury, A. C., Bonebrake, A., Soper, J. T., Mathews, C., Zivanovic, O., Richards, W. E., Tan, A., Alberts, D. S., Barakat, R. R., & Wenzel, L. B. (Accepted/In press). GOG 244 – The Lymphedema and Gynecologic cancer (LeG) study: The impact of lower-extremity lymphedema on quality of life, psychological adjustment, physical disability, and function. Gynecologic Oncology. https://doi.org/10.1016/j.ygyno.2020.10.023
  • Armer, J. M., Anderson, E. A., Armer, N. C., Smith, K. M., & Moffatt, C. (2021). International Lymphoedema Framework Chronic Oedema/Lymphoedema Outcome Measures Project: American Lymphedema Framework Project Stakeholders Report. Journal of Lymphoedema16(1).
  • Anbari, A., Deroche, C., & Armer, J. (2019). Body Mass Index (BMI) trends and quality of life (QOL) from breast cancer diagnosis through seven years’ survivorship. World Journal of Clinical Oncology.
  • Anderson, E., Anbari, A., Armer, N. C., & Armer, J. (2019). Lymphoedema therapists: A national and international survey. Journal of Lymphoedema, 14(1).
  • Armer, J. M., Ballman, K. V., McCall, L., Armer, N. C., Sun, Y., Udmuangpia, T., … Boughey, J. C. (2019). Lymphedema symptoms and Limb Measurement Changes in Breast Cancer Survivors Treated with Neoadjuvant Chemotherapy and Axillary Dissection: Results of ACOSOG Z1071 (Alliance) Substudy. Supportive Care in Cancer 27(2) 495–503. https://doi.org/10.1007/s00520-018-4334-7
  • Sun, Y., & Armer, J. M. (2019). A Nurse’s Twenty-four-year Journey with Breast Cancer-related Lymphedema. WORK: A Journal of Prevention, Assessment & Rehabilitation, 63(1), 21-31. https://doi.org/10.3233/WOR-192904.
    Tidhar, D., Deutscher, D., & Armer, J. M. (2019). Construct Validity of Functional Status Scores of Patients with Lymphedema. Lymphology, 51(4), 160-173.
  • Wanchai, A., & Armer, J. M. (2019). Effects of weight-lifting or resistance exercise on breast cancer-related lymphedema: A systematic review. International Journal of Nursing Sciences, 6(1), 92-98. https://doi.org/10.1016/j.ijnss2018.12.006
  • Chrischilles, E.A., Riley, D., Letuchy, E., Koehler, L., Neuner, J., Jernigan, C., … Armer, J.M., & Lizarraga, I.M. (2019). Upper Extremity Disability and Quality of Life After Breast Cancer Treatment in the Greater Plains Collaborative Clinical Research Network. Breast Cancer Research and Treatment.doi: 10.1007/s10549-019-05184-1
  • Tidhar, D., Deutscher, K., Horn, S.D., Armer J.M. (2019). Treatment Documentation in Practice-Based Evidence Research for Patients Receiving Physical Therapy Due to Lymphedema. Archives of Physical Medicine and Rehabilitation.doi: 10.1016/j.apmr.2019.01.001.
  • Sekyere, M.O., Basson, P., Uys, C., & Armer, J.M. (2018). Incidence of and Risk Factors for Arm Lymphedema Following Breast Cancer Treatment, A Study in Ghana. Journal of Lymphoedema, 13(1): 8-11.
  • Wanchai, A., & Armer, J.M. (2018). Promoting self-care capabilities of patients: Nurses’ roles. JOJ Nursing & Health Care, 7(4). doi:10.19080/JOJNHC.2018.07.555719
  • Tidhar, D., Deutscher, D., & Armer, J.M. (2018). Construct Validity of Functional Status Scores of Patients with Lymphedema. Lymphology, 51,160-173.
  • Wanchai, A., & Armer, J.M. (2018). Effects of Weight-Lifting or Resistance Exercise on Breast Cancer-Related Lymphedema: A Systematic Review. International Journal of Nursing Sciences, 6, 92-98. doi:10.1016/j.ijnss.2018.12.006.
  • Tidhar, D., Armer, J.M., & Stewart, B.R. (2018). What is Clinically Important in Lymphedema Management? A Systematic Review. Rehabilitation Oncology,36(1): 13-27. http://doi.org/10.1097/01.REO.0000000000000093Tesar, E., & Armer, J.M. (2018). Effect of Common Medications on Breast Cancer-Related Lymphedema. Rehabilitation Oncology, 36(1)7-12. http://doi.org/10.1097/01.REO.0000000000000105
  • Tidhar, D., & Armer, J.M. (2018). The meaning of success of lymphoedema management. Journal of Lymphoedema13(1): 37-42
  • Schulz, G.L., Kelly, K.P., Holtmann, M., Doering, M.M., & Armer, J.M. (2017). Decision-making in pediatric hematopoietic cell transplantation: Influential factors vary among diseases. Pediatric Blood and Cancer, doi.org/10.1002/pbc.26890
  • Bernas, M., Thiadens, S.R.J., Smoot, B., Armer, J.M., Stewart, P., & Granzow, J. (2018). Lymphedema Following Cancer Therapy: Overview and Options. Clinical & Experimental Metastasis, 13(1) http://doi.org/10.1007/s10585-018-9899-5
  • Armer, J. M., Ballman, K. V., McCall, L., Armer, N. C., Sun, Y., Udmuangpia, T., … Boughey, J. C. (2018). Lymphedema symptoms and Limb Measurement Changes in Breast Cancer Survivors Treated with Neoadjuvant Chemotherapy and Axillary Dissection: Results of ACOSOG Z1071 (Alliance) Substudy. Supportive Care in Cancer,27(2):495-503. doi: 10.1007/s00520-018-4334-7
        •  

 

Selected Presentations
  • Armer, J. M. (2019, September). Review of the lymphedema symptom tools: lymphedema and breast cancer questionnaire(LBCQ), melanoma and lymphedema questionnaire (MELQ) and gynecologic cancer and lymphedema questionnaire (GCLQ)International Society of Lymphology. Buenos Aires, Argentina: International Society of Lymphology.
  • Armer, J. M. (2019, September). “More than swelling”: Stakeholder engagement in lymphedema researchInternational Society of Lymphology. Buenos Aires, Argentina: International Society of Lymphology.
  • Armer, J. M. (2019, September). A 2018 update to the American Lymphedema Framework Project (ALFP) survey of lymphedema therapists: nine-year comparison of therapist characteristics and practicesInternational Society of Lymphology. Buenos Aires, Argentina: International Society of Lymphology.
  • Armer, J. M. (2019, September). International Lymphedema Framework (ILF) Chronic Oedema /Lymphedema outcome measures (COM) project. US stakeholders report in partnership with ALFPInternational Society of Lymphology. Buenos Aires, Argentina: International Society of Lymphology.
  • Armer, J. M., Balllman, K. V., McCall, L., Ostby, P. L., Zagar, E., Kuerer, H. M., … Boughey, J. C. (2019, June). A Prospective Clinical Trial in Women with node-Positive Breast Cancer Treated with Neoadjuvant Chemotherapy and Axillary Dissection: Factors Associated with Lymphedema (ACOSOG Z1071, Alliance for Clinical Trails in Oncology (Alliance)International Lymphoedema Framework Project/American Lymphedema Framework Project. Chicago, IL: International Lymphoedema Framework Project/American Lymphedema Framework Project.
  • Armer, J. M., Paskett, E., & Oliveri, J. (2019, June). Effects of a lymphedema prevention intervention on range of motion among women receiving lymph note dissection for breast cancer treatment (Alliance) CALGB 70305International Lymphedema Framework and American Lymphedema Framework. Chicago, IL: International Lymphedema Framework and American Lymphedema Framework.
  • Armer, J. M. (2019, June). Lymphedema Symptoms and Limb Measurement: Results of American College of Surgeons Oncology Group (ACOSOG) Z1071 (Alliance) SubstudyNational Institutes of Health. Washington, DC: National Institutes of Health.
  • Armer, J. M. (2019, June). Patient Reported Outcomes for Lower Extremity LymphedemaNational Institutes of Health. Washington, DC: National Institutes of Health.
  • Armer, J. M., & Anbari, A. (2019, March). BMI Trends and Quality of Life from Breast Cancer Diagnosis through Seven Years SurvivorshipMidwest Nursing Research Society. Kansas City, MO: Midwest Nursing Research Society.
  • Armer, J. M. (2019, March). “More than Swelling” Patient Engagement in Lymphedema ManagementUniversity of Missouri. University of Missouri School of Medicine: University of Missouri.
        •  
Link to CV Here